ReviewFrontiers in cellular and infection microbiology2020
Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.
Review in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 25 citations in OpenAlex.
- Amebiasis as a neglected tropical disease: Current knowledge gaps and future directions.PLoS neglected tropical diseases · 2026Review
- Extraintestinal Entamoeba moshkovskii Infection, Eastern India.Emerging infectious diseases · 2026Article
- A retrospective case series of amebic colitis clinical features at a tertiary hospital in Beijing from 2021 to 2024.BMC infectious diseases · 2025Article
- Article
- Recent advances in the diagnosis and management of amoebiasis.Frontline gastroenterology · 2025Review
- AGC family kinase of Entamoeba histolytica: Decoding the members biochemically.PLoS pathogens · 2024Article
- Identification and Characterization of Entamoeba histolytica Choline Kinase.Acta parasitologica · 2024Article
- Pathogenicity and virulence ofVirulence · 2023Review
- Healthy Drinking Water as a Necessity in Developing Countries Like India: A Narrative review.Cureus · 2023Review
- The Amoebicidal Activity of Diferrocenyl Derivatives: A Significant Dependence on the Electronic Environment.Molecules (Basel, Switzerland) · 2023Article
- Essential Oils and Terpenic Compounds as Potential Hits for Drugs against Amitochondriate Protists.Tropical medicine and infectious disease · 2023Review
- High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds.PloS one · 2023Article
- Review
- An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives.Frontiers in cellular and infection microbiology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amebiasis is a neglected tropical disease which is caused by the protozoan parasite
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.